MindWalk Holdings (HYFT) Current Assets (2020 - 2026)
MindWalk Holdings (HYFT) reported Current Assets of $13.6 million for Q1 2026, down 7.21% year-over-year from $14.6 million in Q1 2025, and down 13.48% quarter-over-quarter from $15.7 million in Q4 2025.
MindWalk Holdings (HYFT) Current Assets (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Current Assets data on file, last reported at $13.6 million in Q1 2026.
- Current Assets for Q1 2026 came in at $13.6 million, down 7.21% year-over-year; the trailing twelve-month figure through Jan 2026 was $13.6 million (down 7.21% YoY), and the FY2025 annual result was $13.5 million, up 58.92% from the prior year.
- Current Assets retreated to $13.6 million in Q1 2026 per HYFT's latest filing, from $15.7 million in the prior quarter.
- Over five years, Current Assets peaked at $32.0 million in Q1 2022 and troughed at $8.0 million in Q3 2024.
- A 5-year average of $15.9 million and a median of $13.6 million in 2026 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2025: Current Assets plunged 58.05% in 2023, then soared 227.91% in 2025.
- A 5-year view of Current Assets shows it stood at $17.1 million in 2022, then plunged by 33.47% to $11.4 million in 2023, then dropped by 19.42% to $9.2 million in 2024, then surged by 71.17% to $15.7 million in 2025, then slipped by 13.48% to $13.6 million in 2026.
- Business Quant data shows HYFT's Current Assets at $13.6 million in Q1 2026, $15.7 million in Q4 2025, and $26.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 3.59 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 600.85 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 13.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 13.56 Mn |
| Oct 31, 2025 | 15.67 Mn |
| Jul 31, 2025 | 26.39 Mn |
| Apr 30, 2025 | 13.18 Mn |
| Jan 31, 2025 | 14.61 Mn |
| Oct 31, 2024 | 9.16 Mn |
| Jul 31, 2024 | 8.05 Mn |
| Apr 30, 2024 | 8.47 Mn |
| Jan 31, 2024 | 11.14 Mn |
| Oct 31, 2023 | 11.36 Mn |
| Jul 31, 2023 | 11.78 Mn |
| Apr 30, 2023 | 12.41 Mn |
| Jan 31, 2023 | 13.99 Mn |
| Oct 31, 2022 | 17.08 Mn |
| Jul 31, 2022 | 21.06 Mn |
| Apr 30, 2022 | 29.58 Mn |
| Jan 31, 2022 | 32.04 Mn |
| Oct 31, 2021 | 34.95 Mn |
| Jul 31, 2021 | 38.11 Mn |
| Apr 30, 2021 | 38.81 Mn |